comparemela.com

Latest Breaking News On - Guys formula - Page 1 : comparemela.com

Galectin Therapeutics (NASDAQ:GALT) Cut to Sell at StockNews com

Galectin Therapeutics (NASDAQ:GALT – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Wednesday. Separately, HC Wainwright reissued a “buy” rating and set a $11.00 price target on shares of Galectin Therapeutics in a report on Tuesday, April 9th. Check Out Our Latest […]

Galectin Therapeutics (NASDAQ:GALT) Rating Increased to Hold at StockNews com

StockNews.com upgraded shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) from a sell rating to a hold rating in a report published on Tuesday. Separately, HC Wainwright reissued a buy rating and set a $11.00 target price on shares of Galectin Therapeutics in a research note on Tuesday, April 9th. Get Our Latest Stock Analysis […]

Galectin Therapeutics (NASDAQ:GALT) Upgraded at StockNews com

StockNews.com upgraded shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) from a sell rating to a hold rating in a report released on Tuesday morning. Separately, HC Wainwright restated a buy rating and set a $11.00 price objective on shares of Galectin Therapeutics in a report on Tuesday, April 9th. View Our Latest Report on […]

Galectin Therapeutics (NASDAQ:GALT) Downgraded by StockNews com

Galectin Therapeutics (NASDAQ:GALT) Downgraded by StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

IFM Investors Pty Ltd Has $4 46 Million Position in Owens Corning (NYSE:OC)

IFM Investors Pty Ltd trimmed its position in shares of Owens Corning (NYSE:OC – Free Report) by 1.8% during the first quarter, HoldingsChannel.com reports. The firm owned 26,717 shares of the construction company’s stock after selling 503 shares during the period. IFM Investors Pty Ltd’s holdings in Owens Corning were worth $4,456,000 at the end […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.